ERICA BRUEHLMANN: Open Payments
NPI 1770987448 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 19 payments from 7 companies in 2025. Trend: 2023 $290 · 2024 $646 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $182 |
| Janssen Biotech, Inc. | 4 | $131 |
| Galderma Laboratories, L.P. | 1 | $87 |
| UCB, Inc. | 2 | $62 |
| Incyte Corporation | 2 | $52 |
| Organon LLC | 2 | $49 |
| Botanix SB Inc | 1 | $27 |
Products named: RINVOQ, TREMFYA, NEMLUVIO, Bimzelx, OPZELURA, SKYRIZI, VTAMA, SOFDRA.
Industry payments across MA — which companies pay providers there.
